Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-01-14

Clinical Trial Update: Sustainability of Vitamin D Levels After Repletion With Ergocalciferol In Chronic Kidney Disease Stage 5D [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the durability of vitamin D repletion with ergocalciferol in patients with vitamin D deficiency and end-stage renal disease on hemodi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ergocalciferol (ergocalciferol)

Snippet

Sponsor: Albany College of Pharmacy and Health Sciences | Conditions: Vitamin D Deficiency, Renal Failure Chronic Requiring Hemodialysis | Phase 4 | Status: TERMINATED